Skip to content

Seroprevalence of COVID 19 in children

Sero-prevalence and Clinical profile of SARS-CoV-2 infection in children - Covid 19 kids

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/09/028040
Enrollment
400
Registered
2020-09-24
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

CTMRF KKCTH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All children between 1 month and 18 years

Exclusion criteria

Exclusion criteria: Caretakers and children unwilling to participate Children in whom blood draw is not justified eg anaemia

Design outcomes

Primary

MeasureTime frame
1. Proportion of children with seropositivity for SARS-CoV-2 infection 2. Proportion of asymptomatic children with positive COVID 19 3. Proportion of children who show symptoms or signs of COVID-19 infection 4. Proportion of children with PIMS-TSTimepoint: baseline

Secondary

MeasureTime frame
To corelate the serology titres with the severity of diseaseTimepoint: baseline

Countries

India

Contacts

Public ContactDr Aishwarya Venkataraman

Kanchi Kamakoti CHILDS Trust Hospital (KKCTH)

draishwaryav@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026